How safe are contact lenses?

Article

Ophthalmology organizations voice concerns to FDA on contact lens safety.

Several professional bodies in the US recently outlined key recommendations, which were presented to the FDA, calling for an improvement in contact lens safety; including improved contact lens product testing and universal lens care guidelines for consumers.

The American Academy of Ophthalmology (AAO), the Contact Lens Association of Ophthalmologists, the Cornea Society, and the American Society of Cataract and Refractive Surgery were represented at the meeting.

The number of cases of microbial keratitis, particularly Acanthamoeba keratitis, among contact lens wearers remains steady, despite attempts to improve contact lens disinfection regimens and voluntary recalls of contact lens solutions, according to experts.

"Now is the time to tighten the safety net around contact lens products," said Elmer Tu, MD, AAO spokesperson and director of the cornea and external disease service at the University of Illinois, Chicago. "While improved testing and consumer awareness of lens care guidelines may not prevent future outbreaks of eye infections, they will provide an important additional layer of safety for contact lens wearers."

A concern that some ophthalmologists still have is the practice of "passive verification" of contact lens prescriptions. Through this system, third-party sellers (such as online vendors) of contact lenses notify eye-care professionals (ECPs) of customer requests to purchase contact lenses. Unless the ECP notifies the seller within 8 business hours that the prescription is incorrect, expired, or otherwise problematic, the seller may presume that the prescription is correct and then complete the sale.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.